Form 4: Sarepta Therapeutics Director Richard Barry Reports Stock Option Exercises
SEC Form 4
Director Richard Barry reports exercising stock options and holding a significant amount of Sarepta Therapeutics stock.
Summary
- Richard Barry, a director of Sarepta Therapeutics, reported transactions involving the company's stock on May 13, 2025.
- He exercised stock options to acquire 9,746 shares at $25.18 and 10,500 shares at $13.71.
- Following these transactions, Barry directly owns 2,954,317 shares of common stock.
- He also indirectly owns 240,000 shares through a trust and 10,000 shares through an LLC.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, reflecting neutral sentiment. It simply reports transactions.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency into the actions of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 06/02/2016 | Date exercisable for 9,746 stock options at $25.18 |
| 02/28/2017 | Date exercisable for 10,500 stock options at $13.71 |
| 06/02/2025 | Expiration date for 9,746 stock options at $25.18 |
| 05/13/2025 | Transaction date for stock option exercises. |
| 05/15/2025 | Date of signature for the Form 4 filing. |
| 02/28/2026 | Expiration date for 10,500 stock options at $13.71 |
Keywords
Sarepta Therapeutics, Richard Barry, stock options, Form 4, beneficial ownership, SRPT, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.